Empfehlung
5,3
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | VERTEX PHARMACEUTICALS INC / MA |
|---|---|
| Ticker | VRTX |
| CIK | 0000875320 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | VERTEX PHARMACEUTICALS INC / MA |
Status
| Zuletzt geprüft | 2026-03-20 22:22:49.03606 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 12,001,300,000 | 3,953,200,000 | 15.32 | 25,643,000,000 | 18,665,800,000 |
| 2017-12-31 | 10-K | 2,488,652,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Bozic Carmen | Officer, EVP and CMO | Open Market Sale | -2,329 | 481.79 | -1,122,088.91 | -58,5% | |
| 2026-03-11 | McKechnie Duncan | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,633 | 498.42 | -1,312,339.86 | -68,5% | |
| 2026-03-04 | McKechnie Duncan | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,437 | 475.30 | -1,158,306.10 | -60,4% | |
| 2026-03-02 | Liu Joy | Officer, EVP and Chief Legal Officer | Open Market Sale | -892 | 495.96 | -442,396.32 | -23,1% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -3,498 | 494.33 | -1,729,166.34 | -90,2% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -2,520 | 493.29 | -1,243,090.80 | -64,8% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -949 | 491.30 | -466,243.70 | -24,3% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -2,725 | 490.54 | -1,336,721.50 | -69,7% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -460 | 489.32 | -225,087.20 | -11,7% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -3,278 | 488.27 | -1,600,549.06 | -83,5% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -2,510 | 487.13 | -1,222,696.30 | -63,8% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -240 | 482.84 | -115,881.60 | -6,0% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -120 | 481.50 | -57,780.00 | -3,0% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -400 | 479.75 | -191,900.00 | -10,0% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -1,725 | 496.95 | -857,238.75 | -44,7% | |
| 2026-02-27 | Bozic Carmen | Officer, EVP and CMO | Open Market Sale | -2,329 | 480.31 | -1,118,641.99 | -58,4% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -1,725 | 496.95 | -857,238.75 | -44,7% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -5,995 | 496.16 | -2,974,479.20 | -155,2% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -15,580 | 495.38 | -7,718,020.40 | -402,6% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -120 | 481.50 | -57,780.00 | -3,0% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -400 | 479.75 | -191,900.00 | -10,0% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -5,995 | 496.16 | -2,974,479.20 | -155,2% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -15,580 | 495.38 | -7,718,020.40 | -402,6% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -3,498 | 494.33 | -1,729,166.34 | -90,2% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -2,520 | 493.29 | -1,243,090.80 | -64,8% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -949 | 491.30 | -466,243.70 | -24,3% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -2,725 | 490.54 | -1,336,721.50 | -69,7% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -460 | 489.32 | -225,087.20 | -11,7% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -3,278 | 488.27 | -1,600,549.06 | -83,5% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -2,510 | 487.13 | -1,222,696.30 | -63,8% | |
| 2026-02-27 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Sale | -240 | 482.84 | -115,881.60 | -6,0% | |
| 2026-02-26 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -357 | 483.36 | -172,559.52 | -9,0% | |
| 2026-02-26 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -357 | 483.36 | -172,559.52 | -9,0% | |
| 2026-02-25 | Bunnage Mark E. | Officer, EVP, Chief Scientific Officer | Open Market Sale | -620 | 486.35 | -301,537.00 | -15,7% | |
| 2026-02-25 | Biller Jonathan | Officer, EVP and Chief Legal Officer | Open Market Sale | -945 | 486.35 | -459,600.75 | -24,0% | |
| 2026-02-25 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -223 | 486.35 | -108,456.05 | -5,7% | |
| 2026-02-25 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -223 | 486.35 | -108,456.05 | -5,7% | |
| 2026-02-25 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -1,846 | 486.35 | -897,802.10 | -46,8% | |
| 2026-02-25 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -1,846 | 486.35 | -897,802.10 | -46,8% | |
| 2026-02-25 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -668 | 486.35 | -324,881.80 | -16,9% | |
| 2026-02-25 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -668 | 486.35 | -324,881.80 | -16,9% | |
| 2026-02-25 | McKechnie Duncan | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,500 | 486.35 | -1,215,875.00 | -63,4% | |
| 2026-02-25 | McKechnie Duncan | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,410 | 489.00 | -1,178,490.00 | -61,5% | |
| 2026-02-25 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -260 | 486.35 | -126,451.00 | -6,6% | |
| 2026-02-25 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -260 | 486.35 | -126,451.00 | -6,6% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -1,848 | 465.80 | -860,798.40 | -44,9% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -10,263 | 467.75 | -4,800,518.25 | -250,4% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -19,662 | 468.57 | -9,213,023.34 | -480,6% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -7,241 | 469.61 | -3,400,446.01 | -177,4% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -11,712 | 470.54 | -5,510,964.48 | -287,5% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -4,237 | 471.43 | -1,997,448.91 | -104,2% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -920 | 463.91 | -426,797.20 | -22,3% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -2,730 | 465.05 | -1,269,586.50 | -66,2% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -1,848 | 465.80 | -860,798.40 | -44,9% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -10,263 | 467.75 | -4,800,518.25 | -250,4% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -19,662 | 468.57 | -9,213,023.34 | -480,6% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -7,241 | 469.61 | -3,400,446.01 | -177,4% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -11,712 | 470.54 | -5,510,964.48 | -287,5% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -4,237 | 471.43 | -1,997,448.91 | -104,2% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -2,730 | 465.05 | -1,269,586.50 | -66,2% | |
| 2026-02-19 | Sachdev Amit | Officer, EVP Chief Patient & Ext Af Off | Open Market Sale | -920 | 463.91 | -426,797.20 | -22,3% | |
| 2026-02-18 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -368 | 473.68 | -174,314.24 | -9,1% | |
| 2026-02-18 | Biller Jonathan | Officer, EVP and Chief Legal Officer | Open Market Sale | -1,244 | 473.68 | -589,257.92 | -30,7% | |
| 2026-02-18 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -638 | 473.68 | -302,207.84 | -15,8% | |
| 2026-02-18 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -638 | 473.68 | -302,207.84 | -15,8% | |
| 2026-02-18 | Bunnage Mark E. | Officer, EVP, Chief Scientific Officer | Open Market Sale | -1,182 | 473.68 | -559,889.76 | -29,2% | |
| 2026-02-18 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -817 | 473.68 | -386,996.56 | -20,2% | |
| 2026-02-18 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -817 | 473.68 | -386,996.56 | -20,2% | |
| 2026-02-18 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -368 | 473.68 | -174,314.24 | -9,1% | |
| 2026-02-17 | Biller Jonathan | Officer, EVP and Chief Legal Officer | Open Market Sale | -2,476 | 489.46 | -1,211,902.96 | -63,2% | |
| 2026-02-17 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -609 | 489.46 | -298,081.14 | -15,5% | |
| 2026-02-17 | Bunnage Mark E. | Officer, EVP, Chief Scientific Officer | Open Market Sale | -2,437 | 489.46 | -1,192,814.02 | -62,2% | |
| 2026-02-17 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -1,557 | 489.46 | -762,089.22 | -39,8% | |
| 2026-02-17 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -1,557 | 489.46 | -762,089.22 | -39,8% | |
| 2026-02-17 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -2,031 | 489.46 | -994,093.26 | -51,9% | |
| 2026-02-17 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -609 | 489.46 | -298,081.14 | -15,5% | |
| 2026-02-17 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -2,031 | 489.46 | -994,093.26 | -51,9% | |
| 2026-02-13 | Bhatia Sangeeta N. | Director | Open Market Sale | -266 | 500.00 | -133,000.00 | -6,9% | |
| 2026-02-13 | Biller Jonathan | Officer, EVP and Chief Legal Officer | Open Market Sale | -988 | 499.00 | -493,012.00 | -25,7% | |
| 2026-02-13 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -1,500 | 499.99 | -749,985.00 | -39,1% | |
| 2026-02-13 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -1,500 | 499.99 | -749,985.00 | -39,1% | |
| 2026-02-13 | Bhatia Sangeeta N. | Director | Open Market Sale | -266 | 500.00 | -133,000.00 | -6,9% | |
| 2026-02-11 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -1,751 | 460.43 | -806,212.93 | -42,1% | |
| 2026-02-11 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -1,376 | 460.43 | -633,551.68 | -33,0% | |
| 2026-02-11 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -466 | 460.43 | -214,560.38 | -11,2% | |
| 2026-02-11 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -466 | 460.43 | -214,560.38 | -11,2% | |
| 2026-02-11 | Bunnage Mark E. | Officer, EVP, Chief Scientific Officer | Open Market Sale | -2,021 | 460.43 | -930,529.03 | -48,5% | |
| 2026-02-11 | Biller Jonathan | Officer, EVP and Chief Legal Officer | Open Market Sale | -1,925 | 460.43 | -886,327.75 | -46,2% | |
| 2026-02-11 | Ambrose Kristen | Officer, SVP & Chief Accounting Officer | Open Market Sale | -1,376 | 460.43 | -633,551.68 | -33,0% | |
| 2026-02-11 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -1,751 | 460.43 | -806,212.93 | -42,1% | |
| 2026-01-07 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -4,500 | 474.99 | -2,137,455.00 | -111,5% | |
| 2026-01-07 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -4,500 | 474.99 | -2,137,455.00 | -111,5% | |
| 2026-01-06 | WAGNER CHARLES F JR | Officer, EVP, CO & FO | Open Market Sale | -9,532 | 461.00 | -4,394,252.00 | -229,2% | |
| 2026-01-06 | WAGNER CHARLES F JR | Officer, EVP, CO & FO | Open Market Sale | -9,532 | 461.00 | -4,394,252.00 | -229,2% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -10,360 | 453.34 | -4,696,602.40 | -245,0% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -4,469 | 440.40 | -1,968,147.60 | -102,7% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -1,320 | 441.26 | -582,463.20 | -30,4% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -2,469 | 443.21 | -1,094,285.49 | -57,1% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -4,352 | 444.36 | -1,933,854.72 | -100,9% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -7,899 | 445.56 | -3,519,478.44 | -183,6% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -1,152 | 447.05 | -515,001.60 | -26,9% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -2,320 | 448.78 | -1,041,169.60 | -54,3% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -5,880 | 449.84 | -2,645,059.20 | -138,0% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -5,809 | 451.20 | -2,621,020.80 | -136,7% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -15,681 | 452.20 | -7,090,948.20 | -369,9% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -10,360 | 453.34 | -4,696,602.40 | -245,0% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -2,070 | 455.22 | -942,305.40 | -49,2% | |
| 2025-12-03 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -4,500 | 449.99 | -2,024,955.00 | -105,6% | |
| 2025-12-03 | Tatsis Ourania | Officer, EVP, Chief Reg. & Quality Off. | Open Market Sale | -4,500 | 449.99 | -2,024,955.00 | -105,6% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -2,469 | 443.21 | -1,094,285.49 | -57,1% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -1,320 | 441.26 | -582,463.20 | -30,4% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -4,469 | 440.40 | -1,968,147.60 | -102,7% | |
| 2025-12-03 | Biller Jonathan | Officer, EVP and Chief Legal Officer | Open Market Sale | -347 | 449.00 | -155,803.00 | -8,1% | |
| 2025-12-03 | WAGNER CHARLES F JR | Officer, EVP, CO & FO | Open Market Sale | -7,000 | 461.00 | -3,227,000.00 | -168,3% | |
| 2025-12-03 | WAGNER CHARLES F JR | Officer, EVP, CO & FO | Open Market Sale | -7,000 | 451.00 | -3,157,000.00 | -164,7% | |
| 2025-12-03 | WAGNER CHARLES F JR | Officer, EVP, CO & FO | Open Market Sale | -7,000 | 461.00 | -3,227,000.00 | -168,3% | |
| 2025-12-03 | WAGNER CHARLES F JR | Officer, EVP, CO & FO | Open Market Sale | -7,000 | 451.00 | -3,157,000.00 | -164,7% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -4,352 | 444.36 | -1,933,854.72 | -100,9% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -7,899 | 445.56 | -3,519,478.44 | -183,6% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -1,152 | 447.05 | -515,001.60 | -26,9% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -2,320 | 448.78 | -1,041,169.60 | -54,3% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -5,880 | 449.84 | -2,645,059.20 | -138,0% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -5,809 | 451.20 | -2,621,020.80 | -136,7% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -15,681 | 452.20 | -7,090,948.20 | -369,9% | |
| 2025-12-03 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -2,070 | 455.22 | -942,305.40 | -49,2% | |
| 2025-11-17 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -2,500 | 434.58 | -1,086,450.00 | -56,7% | |
| 2025-11-17 | Atkinson Edward Morrow III | Officer, EVP, Chief Technical Ops. Off. | Open Market Sale | -2,500 | 434.58 | -1,086,450.00 | -56,7% | |
| 2025-11-14 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -21,330 | 441.35 | -9,413,995.50 | -491,1% | |
| 2025-11-14 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -32,234 | 440.30 | -14,192,630.20 | -740,3% | |
| 2025-11-14 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -40 | 442.00 | -17,680.00 | -0,9% | |
| 2025-11-14 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -21,330 | 441.35 | -9,413,995.50 | -491,1% | |
| 2025-11-14 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -32,234 | 440.30 | -14,192,630.20 | -740,3% | |
| 2025-11-14 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -40 | 442.00 | -17,680.00 | -0,9% | |
| 2025-11-13 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -1,160 | 441.05 | -511,618.00 | -26,7% | |
| 2025-11-13 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -1,160 | 441.05 | -511,618.00 | -26,7% | |
| 2025-11-13 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -18,528 | 440.22 | -8,156,396.16 | -425,5% | |
| 2025-11-13 | LEIDEN JEFFREY M | Director, Officer, Executive Chairman | Open Market Sale | -18,528 | 440.22 | -8,156,396.16 | -425,5% | |
| 2025-10-02 | Biller Jonathan | Officer, EVP and Chief Legal Officer | Open Market Sale | -694 | 404.21 | -280,521.74 | -14,6% | |
| 2025-08-27 | Bhatia Sangeeta N. | Director | Open Market Sale | -266 | 386.69 | -102,859.54 | -5,4% | |
| 2025-08-27 | Bhatia Sangeeta N. | Director | Open Market Sale | -266 | 386.69 | -102,859.54 | -5,4% | |
| 2025-08-06 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Purchase | 5,710 | 389.95 | 2,226,614.50 | +116,1% | |
| 2025-08-06 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Purchase | 4,290 | 389.08 | 1,669,153.20 | +87,1% | |
| 2025-08-06 | SACHS BRUCE I | Director | Open Market Purchase | 1,634 | 389.36 | 636,214.24 | +33,2% | |
| 2025-08-06 | SACHS BRUCE I | Director | Open Market Purchase | 3,366 | 389.84 | 1,312,201.44 | +68,4% | |
| 2025-08-06 | SACHS BRUCE I | Director | Open Market Purchase | 1,634 | 389.36 | 636,214.24 | +33,2% | |
| 2025-08-06 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Purchase | 5,710 | 389.95 | 2,226,614.50 | +116,1% | |
| 2025-08-06 | SACHS BRUCE I | Director | Open Market Purchase | 3,366 | 389.84 | 1,312,201.44 | +68,4% | |
| 2025-08-06 | Kewalramani Reshma | Director, Officer, CEO & President | Open Market Purchase | 4,290 | 389.08 | 1,669,153.20 | +87,1% | |
| 2025-05-15 | ALTSHULER DAVID | Officer, EVP, Chief Scientific Officer | Open Market Sale | -52 | 424.69 | -22,083.88 | -1,2% | |
| 2025-05-02 | Bhatia Sangeeta N. | Director | Open Market Sale | -400 | 505.86 | -202,344.00 | -10,6% | |
| 2025-05-02 | Bhatia Sangeeta N. | Director | Open Market Sale | -400 | 505.86 | -202,344.00 | -10,6% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.